Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ares Management CorpARES · Entity 3048 | Director | July 30, 2026 | August 04, 2026 |
| MATTEL INC /DE/MAT · Entity 1046 | Director | May 28, 2026 | June 01, 2026 |
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | Director | July 22, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ares Management Corp
Report date July 30, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 31,462 |
Reported balance
After 2026-07-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-30 · Grant · Acquired 1,728 · Balance 31,462 F1: Granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are scheduled to lapse on the first anniversary of the grant date. F2: Includes 1,728 restricted units granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are scheduled to lapse on the first anniversary of the grant date.
F2: Includes 1,728 restricted units granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement.
MATTEL INC /DE/
Report date May 28, 2026 · Filed June 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,753 |
Reported balance
After 2026-05-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 11,753 · Balance 11,753 F1: The Restricted Stock Units ("RSUs" or "Units") were granted on May 28, 2026 pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. The RSUs are accompanied by dividend equivalent rights. F2: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant or such later date in accordance with the terms of the Mattel, Inc. Deferred Compensation Plan for Non-Employee Directors. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Mattel, Inc. Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units ("RSUs" or "Units") were granted on May 28, 2026 pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. The RSUs are accompanied by dividend equivalent rights.
F2: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant or such later date in accordance with the terms of the Mattel, Inc. Deferred Compensation Plan for Non-Employee Directors. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Mattel, Inc. Common Stock.
UNITED THERAPEUTICS Corp
Report date July 22, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 760 |
Reported balance
After 2026-07-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-22 · Grant · Acquired 760 · Balance 760 F1: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2: Annual non-employee director award. F3: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. F4: Not applicable as restricted stock units do not have an expiration date. |
| Common StockSEC Table I · non-derivative | Direct | 5,555 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,555 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F2: Annual non-employee director award.
F3: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
F4: Not applicable as restricted stock units do not have an expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 30, 2026 Filed Aug 4, 2026 01:38 UTC | Ares Management Corp ARES · Entity 3048 | GrantClass A Common Stock | 1,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001605729-26-000015 · wk-form4_1785807502.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,462 F1 · shares: Granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are scheduled to lapse on the first anniversary of the grant date. F2 · balance_after: Includes 1,728 restricted units granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. Read SEC document |
| July 22, 2026 Filed Jul 23, 2026 20:44 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 760 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001605729-26-000013 · primarydocument.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 760 Underlying: Common Stock · 760 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director award. F3 · derivative.exercise_date: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:35 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 1,310 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001605729-26-000012 · primarydocument.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,310 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · kind: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:35 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001605729-26-000012 · primarydocument.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 21:56 UTC | MATTEL INC /DE/ MAT · Entity 1046 | GrantRestricted Stock Units · Derivative | 11,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001605729-26-000011 · wk-form4_1780350978.xml · derivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,753 Underlying: Common Stock · 11,753 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs" or "Units") were granted on May 28, 2026 pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. The RSUs are accompanied by dividend equivalent rights. F2 · derivative.exercise_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant or such later date in accordance with the terms of the Mattel, Inc. Deferred Compensation Plan for Non-Employee Directors. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Mattel, Inc. Common Stock. F2 · derivative.expiration_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant or such later date in accordance with the terms of the Mattel, Inc. Deferred Compensation Plan for Non-Employee Directors. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Mattel, Inc. Common Stock. Read SEC document |
| May 15, 2026 Filed May 19, 2026 21:29 UTC | MATTEL INC /DE/ MAT · Entity 1046 | Exercise / conversionRestricted Stock Units · Derivative | 8,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001605729-26-000008 · wk-form4_1779226143.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As reported on a Form 4 dated May 15, 2023 and filed on May 17, 2023, the Reporting Person received a grant of 8,594 Restricted Stock Units ("RSUs") on May 15, 2023. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 15, 2026, 100% of these RSUs were settled, resulting in the issuance of 8,594 shares of Mattel Common Stock. F1 · derivative.exercise_date: As reported on a Form 4 dated May 15, 2023 and filed on May 17, 2023, the Reporting Person received a grant of 8,594 Restricted Stock Units ("RSUs") on May 15, 2023. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 15, 2026, 100% of these RSUs were settled, resulting in the issuance of 8,594 shares of Mattel Common Stock. F1 · derivative.expiration_date: As reported on a Form 4 dated May 15, 2023 and filed on May 17, 2023, the Reporting Person received a grant of 8,594 Restricted Stock Units ("RSUs") on May 15, 2023. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 15, 2026, 100% of these RSUs were settled, resulting in the issuance of 8,594 shares of Mattel Common Stock. Read SEC document |
| May 15, 2026 Filed May 19, 2026 21:29 UTC | MATTEL INC /DE/ MAT · Entity 1046 | Exercise / conversionCommon Stock | 8,594 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001605729-26-000008 · wk-form4_1779226143.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: As reported on a Form 4 dated May 15, 2023 and filed on May 17, 2023, the Reporting Person received a grant of 8,594 Restricted Stock Units ("RSUs") on May 15, 2023. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 15, 2026, 100% of these RSUs were settled, resulting in the issuance of 8,594 shares of Mattel Common Stock. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 200 | $530.00 | $106,000.00 |
DisclosureSEC source: 0001605729-26-000006 · primarydocument.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,245 F1 · kind: This is a sale of common stock pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on November 4, 2025. Read SEC document |
| March 16, 2026 Filed Mar 16, 2026 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 200 | $535.44 | $107,088.00 |
DisclosureSEC source: 0001605729-26-000005 · primarydocument.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,445 F1 · kind: This is a sale of common stock pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on November 24, 2025. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 20:36 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 200 | $510.00 | $102,000.00 |
DisclosureSEC source: 0001605729-26-000004 · primarydocument.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,645 F1 · kind: This is a sale of common stock pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on November 24, 2025. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 200 | $509.55 | $101,910.00 |
DisclosureSEC source: 0001605729-26-000003 · primarydocument.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,845 F1 · kind: This is a sale of common stock pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on November 24, 2025. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:50 UTC | Ares Management Corp ARES · Entity 3048 | PurchaseClass A Common Stock | 480 | $124.43 | $59,726.40 |
DisclosureSEC source: 0001605729-26-000002 · wk-form4_1771977029.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,734 F1 · balance_after: Includes 1,166 restricted units granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. Read SEC document |
| September 19, 2025 Filed Sep 19, 2025 20:49 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,800 | $415.43 | $747,767.88 |
DisclosureSEC source: 0001605729-25-000004 · primarydocument.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,045 F1 · price: This transaction was executed in multiple trades at prices ranging from $415.29 to $415.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 31, 2025 Filed Aug 5, 2025 01:38 UTC | Ares Management Corp ARES · Entity 3048 | GrantClass A Common Stock | 1,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-037570 · wk-form4_1754357894.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,254 F1 · shares: Granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are scheduled to lapse on the first anniversary of the grant date. F2 · balance_after: Includes 1,166 restricted units granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:26 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 1,190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005529 · primarydocument.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:26 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005529 · primarydocument.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F1 · price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:26 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 1,310 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005529 · primarydocument.xml · derivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,310 Underlying: Common Stock · 1,310 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · shares: Annual non-employee director award. F1 · price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| May 28, 2025 Filed May 30, 2025 22:25 UTC | MATTEL INC /DE/ MAT · Entity 1046 | GrantRestricted Stock Units · Derivative | 9,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-25-000086 · wk-form4_1748643921.xml · derivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,196 Underlying: Common Stock · 9,196 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") were granted on May 28, 2025, pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. Each RSU represents a contingent right to receive one share of Mattel, Inc. Common Stock. The RSUs are accompanied by dividend equivalent rights. F2 · derivative.exercise_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant or such later date in accordance with the terms of the Mattel, Inc. Deferred Compensation Plan for Non-Employee Directors. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Mattel, Inc. Common Stock. F2 · derivative.expiration_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant or such later date in accordance with the terms of the Mattel, Inc. Deferred Compensation Plan for Non-Employee Directors. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Mattel, Inc. Common Stock. Read SEC document |
| May 23, 2025 Filed May 28, 2025 21:06 UTC | MATTEL INC /DE/ MAT · Entity 1046 | Exercise / conversionRestricted Stock Units · Derivative | 6,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-25-000069 · wk-form4_1748466408.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,843 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As reported on a Form 4 dated May 25, 2022 and filed on May 27, 2022, the Reporting Person received a grant of 6,843 Restricted Stock Units ("RSUs") on May 25, 2022. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 23, 2025, 100% of these RSUs were settled, resulting in the issuance of 6,843 shares of Mattel Common Stock. F1 · derivative.exercise_date: As reported on a Form 4 dated May 25, 2022 and filed on May 27, 2022, the Reporting Person received a grant of 6,843 Restricted Stock Units ("RSUs") on May 25, 2022. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 23, 2025, 100% of these RSUs were settled, resulting in the issuance of 6,843 shares of Mattel Common Stock. F1 · derivative.expiration_date: As reported on a Form 4 dated May 25, 2022 and filed on May 27, 2022, the Reporting Person received a grant of 6,843 Restricted Stock Units ("RSUs") on May 25, 2022. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 23, 2025, 100% of these RSUs were settled, resulting in the issuance of 6,843 shares of Mattel Common Stock. Read SEC document |
| May 23, 2025 Filed May 28, 2025 21:06 UTC | MATTEL INC /DE/ MAT · Entity 1046 | Exercise / conversionCommon Stock | 6,843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001523711-25-000069 · wk-form4_1748466408.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: As reported on a Form 4 dated May 25, 2022 and filed on May 27, 2022, the Reporting Person received a grant of 6,843 Restricted Stock Units ("RSUs") on May 25, 2022. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 23, 2025, 100% of these RSUs were settled, resulting in the issuance of 6,843 shares of Mattel Common Stock. Read SEC document |
| December 12, 2024 Filed Dec 17, 2024 00:09 UTC | Ares Management Corp ARES · Entity 3048 | GiftClass A Common Stock | 397 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-051572 · wk-form4_1734394150.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,088 F1 · shares: Represents the number of shares of Class A Common Stock which were donated to a charity by the Reporting Person on December 12, 2024. F2 · balance_after: Includes 1,173 restricted units granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,750 | $412.48 | $721,840.00 |
DisclosureSEC source: 0001415889-24-026614 · form4-11122024_041127.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,655 Read SEC document |
| September 17, 2024 Filed Sep 17, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 2,300 | $0.00 Strike: $112.14 | $0.00 |
DisclosureSEC source: 0001415889-24-023521 · form4-09172024_040903.xml · derivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,320 Underlying: Common Stock · 2,300 shares Expires 2028-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2024 Filed Sep 17, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,300 | $353.22 | $812,406.00 |
DisclosureSEC source: 0001415889-24-023521 · form4-09172024_040903.xml · nonDerivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2024 Filed Sep 17, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,300 | $112.14 | $257,922.00 |
DisclosureSEC source: 0001415889-24-023521 · form4-09172024_040903.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 23:58 UTC | Ares Management Corp ARES · Entity 3048 | GrantClass A Common Stock | 1,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-034887 · wk-form4_1722902277.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,485 F1 · shares: Granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are scheduled to lapse on the first anniversary of the grant date. F2 · balance_after: Includes 1,173 restricted units granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 1,190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-020174 · form4-07262024_040731.xml · derivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,190 Underlying: Common Stock · 1,190 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director award. F3 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date. F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 13, 2024 Filed Jul 15, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 1,800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019550 · form4-07152024_040710.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · kind: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 13, 2024 Filed Jul 15, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019550 · form4-07152024_040710.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,700 | $295.43 | $502,225.39 |
DisclosureSEC source: 0001415889-24-017415 · form4-06182024_040608.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,605 Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 01:48 UTC | Ares Management Corp ARES · Entity 3048 | SaleClass A Common Stock | 3,417 | $134.00 | $457,864.67 |
DisclosureSEC source: 0001628280-24-027600 · wk-form4_1718070513.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,312 F1 · balance_after: Includes 2,383 restricted units granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. Read SEC document |
| May 29, 2024 Filed May 31, 2024 21:36 UTC | MATTEL INC /DE/ MAT · Entity 1046 | GrantRestricted Stock Units · Derivative | 9,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-24-000090 · wk-form4_1717191387.xml · derivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,972 Underlying: Common Stock · 9,972 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") were granted on May 29, 2024, pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. Each RSU represents a contingent right to receive one share of Mattel, Inc. Common Stock. The RSUs are accompanied by dividend equivalent rights. F2 · derivative.exercise_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Mattel, Inc. Common Stock. F2 · derivative.expiration_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Mattel, Inc. Common Stock. Read SEC document |
| May 24, 2024 Filed May 29, 2024 22:59 UTC | MATTEL INC /DE/ MAT · Entity 1046 | Exercise / conversionCommon Stock | 7,539 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001523711-24-000065 · wk-form4_1717023549.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: As reported on a Form 4 dated May 26, 2021 and filed on May 28, 2021, the Reporting Person received a grant of 7,539 Restricted Stock Units ("RSUs") on May 26, 2021. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 24, 2024, 100% of these RSUs were settled, resulting in the issuance of 7,539 shares of Mattel, Inc. Common Stock. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 10,000 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-24-012330 · form4-05062024_040507.xml · derivative · entry 7 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 170 | $260.77 | $44,330.36 |
DisclosureSEC source: 0001415889-24-012330 · form4-05062024_040507.xml · nonDerivative · entry 6 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,305 Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,157 | $259.70 | $300,472.09 |
DisclosureSEC source: 0001415889-24-012330 · form4-05062024_040507.xml · nonDerivative · entry 5 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,475 F4 · price: This transaction was executed in multiple trades at prices ranging from $259.455 to $260.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 5,616 | $258.90 | $1,453,954.32 |
DisclosureSEC source: 0001415889-24-012330 · form4-05062024_040507.xml · nonDerivative · entry 4 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,632 F3 · price: This transaction was executed in multiple trades at prices ranging from $258.455 to $259.445. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,829 | $257.89 | $471,685.75 |
DisclosureSEC source: 0001415889-24-012330 · form4-05062024_040507.xml · nonDerivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,248 F2 · price: This transaction was executed in multiple trades at prices ranging from $257.33 to $258.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,228 | $256.64 | $315,158.83 |
DisclosureSEC source: 0001415889-24-012330 · form4-05062024_040507.xml · nonDerivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,077 F1 · price: This transaction was executed in multiple trades at prices ranging from $256.25 to $257.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 10,000 | $175.43 | $1,754,300.00 |
DisclosureSEC source: 0001415889-24-012330 · form4-05062024_040507.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 5,000 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-24-007815 · form4-03132024_040304.xml · derivative · entry 5 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,750 | $248.90 | $435,577.98 |
DisclosureSEC source: 0001415889-24-007815 · form4-03132024_040304.xml · nonDerivative · entry 4 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,305 F3 · price: This transaction was executed in multiple trades at prices ranging from $248.69 to $248.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,500 | $248.03 | $620,069.50 |
DisclosureSEC source: 0001415889-24-007815 · form4-03132024_040304.xml · nonDerivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,055 F2 · price: This transaction was executed in multiple trades at prices ranging from $247.61 to $248.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 750 | $247.15 | $185,358.90 |
DisclosureSEC source: 0001415889-24-007815 · form4-03132024_040304.xml · nonDerivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,555 F1 · price: This transaction was executed in multiple trades at prices ranging from $246.60 to $247.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $175.43 | $877,150.00 |
DisclosureSEC source: 0001415889-24-007815 · form4-03132024_040304.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2023 Filed Dec 1, 2023 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GiftCommon Stock | 950 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-015692 · form4-12012023_041207.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,305 F1 · price: Bona fide charitable contribution to a donor advised fund. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 21:15 UTC | MATTEL INC /DE/ MAT · Entity 1046 | Exercise / conversionRestricted Stock Units · Derivative | 12,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-23-000082 · wf-form4_169101090855059.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,601 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As reported on a Form 4 dated July 31, 2020 and filed on August 4, 2020, the Reporting Person received a grant of 12,601 Restricted Stock Units ("RSUs") on July 31, 2020. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On July 31, 2023, 100% of these RSUs were settled, resulting in the issuance of 12,601 shares of Mattel, Inc. Common Stock. F1 · derivative.exercise_date: As reported on a Form 4 dated July 31, 2020 and filed on August 4, 2020, the Reporting Person received a grant of 12,601 Restricted Stock Units ("RSUs") on July 31, 2020. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On July 31, 2023, 100% of these RSUs were settled, resulting in the issuance of 12,601 shares of Mattel, Inc. Common Stock. F1 · derivative.expiration_date: As reported on a Form 4 dated July 31, 2020 and filed on August 4, 2020, the Reporting Person received a grant of 12,601 Restricted Stock Units ("RSUs") on July 31, 2020. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On July 31, 2023, 100% of these RSUs were settled, resulting in the issuance of 12,601 shares of Mattel, Inc. Common Stock. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 21:15 UTC | MATTEL INC /DE/ MAT · Entity 1046 | Exercise / conversionCommon Stock | 12,601 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001523711-23-000082 · wf-form4_169101090855059.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: As reported on a Form 4 dated July 31, 2020 and filed on August 4, 2020, the Reporting Person received a grant of 12,601 Restricted Stock Units ("RSUs") on July 31, 2020. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On July 31, 2023, 100% of these RSUs were settled, resulting in the issuance of 12,601 shares of Mattel, Inc. Common Stock. Read SEC document |
| July 27, 2023 Filed Aug 1, 2023 00:17 UTC | Ares Management Corp ARES · Entity 3048 | GrantClass A Common Stock | 1,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-026303 · wk-form4_1690849013.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,729 F1 · shares: Granted under the Ares Management Corporation 2023 Equity Incentive Plan (the "Equity Incentive Plan"). Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are scheduled to lapse on the first anniversary of the grant date. F2 · balance_after: Includes 3,431 restricted units granted under the Equity Incentive Plan. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 10:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 1,800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-011158 · form4-07172023_060722.xml · derivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 1,800 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director award. F3 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.